SCHEMBL7677777

SCHEMBL7677777

COCc1ccccc1[C]=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.47
ALDH1A1 P00352 5/20 0.35
TSHR P16473 2/20 0.35
CASP1 P29466 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
IDO1 P14902 2/20 0.34
PDK2 Q15119 1/20 0.34
GAA P10253 2/20 0.33
KDM4E B2RXH2 2/20 0.33
CCNT1 O60563 1/20 0.33
CDK1 P06493 1/20 0.33
CDK4 P11802 1/20 0.33
CCNB1 P14635 1/20 0.33
CCND1 P24385 1/20 0.33
CDK2 P24941 1/20 0.33
CCND3 P30281 1/20 0.33
GSK3B P49841 1/20 0.33
CDK9 P50750 1/20 0.33
CDK3 Q00526 1/20 0.33
CDK6 Q00534 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21319325 0.80 FFAR1 (0.55) FFAR1ALDH1A1TSHRCASP1SMN1; SMN2
SCHEMBL7672866 0.80 L3MBTL1 (0.34) FFAR1ALDH1A1TSHRIDO1GAA
SCHEMBL7390132 0.80 TSHR (0.39) FFAR1ALDH1A1TSHRGAAKDM4E
SCHEMBL9527621 0.79 FFAR1 (0.43) FFAR1ALDH1A1TSHRCASP1SMN1; SMN2
SCHEMBL515210 0.79 ALDH1A1 (0.48) FFAR1ALDH1A1TSHRSMN1; SMN2GAA
SCHEMBL535892 0.78 GABRA1 (0.45) FFAR1ALDH1A1GAANPSR1L3MBTL1
SCHEMBL442437 0.77 ALDH1A1 (0.52) FFAR1ALDH1A1TSHRSMN1; SMN2KDM4E
SCHEMBL648491 0.77 IDO1 (0.44) FFAR1ALDH1A1TSHRCASP1SMN1; SMN2
SCHEMBL6211880 0.76 FFAR1 (0.49) FFAR1SMN1; SMN2KDM4E
SCHEMBL522138 0.76 FFAR1 (0.31) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US disclosed
EP-1001943-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP disclosed
WO-1999003843-A1 POLYHYDROXYALKYLPYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO disclosed
EP-0487095-B1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation THOMAE GMBH DR K (DE) 1996-02-28 EP disclosed
US-5286736-A Thromboxane antagonists and thromboxane synthetase inhibitors DR. KARL THOMAE GMBH (DE) 1994-02-15 US disclosed
EP-0487095-A1 Pyridyl derivatives, medicines containing these compounds and processes for their preparation Dr. Karl Thomae GmbH (DE) 1992-05-27 EP disclosed